SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-24-000013
Filing Date
2024-03-07
Accepted
2024-03-07 15:28:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3155
  Complete submission text file 0001974158-24-000013.txt   4637
Mailing Address C/O TARGANTA THERAPEUTICS CORPORATION 222 THIRD STREET SUITE 2300 CAMBRIDGE MA 02142
Business Address
Eldridge George A (Reporting) CIK: 0001413006 (see all company filings)

Type: 144

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Subject) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40544 | Film No.: 24729772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)